ADIPOQ and gestational diabetes: Most studies report an increase of adiponectin in the third trimester of gestation in patients with preeclampsia compared to control (Pérez-Pérez et al., 2020; Pheiffer et al., 2021; Lara-Barea et al., 2022), while others found the Other adipokines such as resistin, visfatin and vaspin in gestational diabetes and preeclampsia have been described but their physiological role has yet to be established and work has been more descriptive regarding these other adipokines (Miehle et al., 2012).